SCHEMBL12611404

SCHEMBL12611404

CCCn1cc(-c2ccnc(Nc3cccc([N+](=O)[O-])c3)n2)c2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 4/20 0.59
▸ CDK2 P24941 6/20 0.58
▸ CDK4 P11802 5/20 0.58
▸ SLC2A1 P11166 1/20 0.58
▸ ABL1 P00519 4/20 0.56
▸ BCR P11274 3/20 0.56
▸ PRKCA P17252 3/20 0.56
▸ MKNK1 Q9BUB5 1/20 0.56
▸ MKNK2 Q9HBH9 1/20 0.56
▸ EGFR P00533 9/20 0.56
▸ SRC P12931 1/20 0.53
▸ CCNT1 O60563 2/20 0.50
▸ CDK1 P06493 2/20 0.50
▸ CCNB1 P14635 2/20 0.50
▸ CCNA2 P20248 2/20 0.50
▸ CDK7 P50613 2/20 0.50
▸ CDK9 P50750 2/20 0.50
▸ CCNH P51946 2/20 0.50
▸ AURKA O14965 1/20 0.50
▸ CCNB2 O95067 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2541907 0.89 GSK3B (0.60) GSK3BCDK2CDK4SLC2A1ABL1
SCHEMBL2543297 0.83 ABL1 (0.57) GSK3BCDK2CDK4SLC2A1ABL1
SCHEMBL2539834 0.76 MKNK2 (0.62) GSK3BCDK2CDK4MKNK1MKNK2
SCHEMBL12611335 0.75 CDK1 (0.69) GSK3BCDK2SLC2A1MKNK2EGFR
SCHEMBL4513070 0.74 ABL1 (0.64) GSK3BCDK2CDK4SLC2A1ABL1
SCHEMBL4478642 0.74 CDK2 (1.00) GSK3BCDK2CDK4SLC2A1ABL1
SCHEMBL2545958 0.74 CDK1 (0.61) GSK3BCDK2SLC2A1MKNK1MKNK2
SCHEMBL27809421 0.73 GSK3B (0.61) GSK3BCDK2CDK4MKNK1MKNK2
SCHEMBL1886 0.73 ABL1 (1.00) GSK3BCDK2CDK4SLC2A1ABL1
SCHEMBL4737544 0.73 CDK2 (0.65) GSK3BCDK2CDK4SLC2A1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012126181-A1 USE OF KINASE INHIBITORS IN PREVENTING AND TREATING INFLAMMATORY DISORDER LUO YING (CN) 2012-09-27 — — WO disclosed
Send feedback